tirzepatide pots Not all GLP-1–based therapies Package Size:1-month supply Liquid

tirzepatide pots Not all GLP-1–based therapies Package Size:1-month supply Liquid

Not all GLP-1–based therapies work the same way. Semaglutide targets the GLP-1 receptor, while tirzepatide targets both GLP-1 and GIP receptors. Retatrutide is being studied as a triple-receptor agonist targeting GLP-1, GIP

Services Integrative Medicinemore info Bioidentical Hormone Replacement Therapy (BHRT)more info Weight Loss & GLP-1 Therapymore info Thyroid Disease Managementmore info Thermography Screeningmore info Menopause & Perimenopause Supportmore info Osteoporosis & Osteopenia Treatmentmore info Testosterone Replacement Therapy for Womenmore info Hair Loss Treatment for Womenmore info Specialized Gynecology Servicesmore info Sexual Health, STI Testing & Annual Examsmore info Functional Medicinemore info Insomnia & Sleep Disorder Treatmentmore info

Liquid

Package Size:1-month supply

This typically occurs at higher doses or in individuals with especially responsive GLP-1 receptors